Sunshine Holdings Plc · CSELK:SUN.N0000
Sunshine — 1QFY22 Earnings Presentation
16 slides from Sunshine's earnings presentation, Aug 5, 2021
Slide 1: Earnings Presentation 1QFY22
Earnings Presentation 1QFY22 5th August 2021
Slide 2: Group Performance
Group Performance
Slide 3: Group at a Glance – 1QFY22
Group at a Glance – 1QFY22 Note: 1QFY21 adjusted to reflect Daintee Ltd and Akbar Pharmaceuticals (Pvt) Ltd performance. • LKR 7.3bn in Revenue; +28.7% YoY • LKR 1.0bn PAT; +69.2%YoY • PATMI of LKR 333m; Revenue - 1QFY22 Other, 1% • Healthcare revenue; LKR 4.0bn; +28.7% YoY Consumer, • Agri revenue;
Slide 4: Group Financial Highlights
Group Financial Highlights Adj. Reported LKR m 1Q FY22 1Q FY21 Growth % 1QFY21 Revenue 7,348 5,710 28.7% 4,786 EBIT 1,320 987 33.7% 860 EBIT margin 18.0% 17.3% 18.0% PAT 1,040 615 69.2% 553 PAT margin 14.2% 10.8% PATMI 333 381 -12.8% 321 EPS (LKR) 0.74 0.85 -12.8% 0.72 *comparative figure adjusted t
Slide 5: 1Q Revenue Growth Trend
1Q Revenue Growth Trend • 5 Year CAGR of 10% 5 Yr CAGR: 10% 8,000 7,348 40% 7,000 33% 6,164 29% 30% 6,000 5,575 5,710 22% 20% 5,000 4,621 4,696 LKR million 4,000 11% 10% 3,000 0% 2,000 -10% -10% 1,000 -16% - -20% 1QFY17 1QFY18 1QFY19 1QFY20 1QFY21 1QFY22 Revenue Revenue Growth Note: 1QFY21 results a
Slide 6: 1Q Profitability
1Q Profitability 1,200 16% 1,040 14% 1,000 14% 12% 800 11% 9% 10% LKR million 9% 615 600 561 8% 6% 408 6% 6% 400 341 291 4% 200 2% - 0% 1QFY17 1QFY18 1QFY19 1QFY20 1QFY21 1QFY22 PAT PAT Margin Note: 1QFY21 results are adjusted to reflect Daintee Ltd and APL performance • Net profit of 1,040m compare
Slide 7: Segment Performance
Segment Performance
Slide 8: Healthcare
Healthcare Adj. LKR m 1Q FY22 1Q FY21* Growth % Revenue 4,000 3,109 28.7% EBIT 401 339 18.3% EBIT margin 10.0% 10.9% PAT 270 197 37.1% PAT margin 6.8% 6.3% *comparative figure adjusted to include businesses purchased during FY21 Highlights • 1QFY22 Revenue up by 28.5% YoY due to higher sales volume
Slide 9: Retail
Retail 12 Outlets in Colombo, and 1 online store Highlights • 1QFY22 revenue had increased 71.2% YoY • Improved digital platform and delivery services • Loyalty engagement improvement • Improve pharma availability • Adjusting to the new normal with change in shopper buying habits
Slide 10: Consumer
Consumer Adj. LKR m 1Q FY22 1Q FY21* Growth % Revenue 1,860 1,518 22.5% EBIT 100 156 -36.0% EBIT margin 5.4% 10.3% PAT 61 135 -54.8% PAT margin 3.3% 8.9% *comparative figure adjusted to include businesses purchased during FY21 Highlights • Revenue increase 22.5% compared to adjusted 1QFY21 • Volume
Slide 11: Agri
Agri LKR m 1Q FY22 1Q FY21 Growth % Revenue 1,404 974 44.2% EBIT 784 497 57.8% EBIT margin 55.8% 51.0% PAT 724 406 78.1% PAT margin 51.5% 41.7% Highlights • Revenue increased by 44.2% YoY mainly due to increase in NSA in the palm oil subsector • Current herd in the Dairy Farm established at 1,645 an
Slide 12: Additional data for analysts
Additional data for analysts 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q LKR m FY19 FY19 FY19 FY20 FY20 FY20 FY20 FY21 FY21 FY21 FY21 FY22 Revenue 5,294 5,768 6,006 5,210 5,327 5,280 5,010 4,786 6,164 6,449 6.940 7,348 PAT 443 501 -139 573 660 467 133 553 733 602 650 1,040 PATMI 234 274 -144 333 398 286 96
Slide 13: Outlook
Outlook
Slide 14: Outlook for 2Q FY22
Outlook for 2Q FY22 Healthcare Consumer Agri • LKR depreciation to • Drive distribution • Higher palm oil NSA impact margins synergies in retail • Marginal growth in • Low occupancy levels channels volume expected in hospitals expected • Focus on brands to • Expand the herd to during 2QFY22 scale do
Slide 15: Forward Looking Statements
Forward Looking Statements This presentation contains forward-looking statements that are based on management’s current expectations and assumptions. Forward-looking statements include predictions of future results or activities and may contain the words “expects,” “believes,” “should,” “will,” “ant
Slide 16: Thank you
Thank you For more information, Please visit our Investor Relations page http://www.sunshineholdings.lk/investor%20relations/index.php